Cure Alliance scientists, after two years of fighting COVID-19, return to their original missions
The Cure Alliance is a boutique 501(c)(3) non-profit group of top scientists, researchers, medical doctors and innovators, plus those who support our efforts to end human suffering by developing cures for chronic, debilitating and fatal diseases.
Our #1 goal has always been to help accelerate potential cures from the laboratory to the patient’s bedside.
Today, with great urgency, our priority is to tear down the remaining barriers to curing diseases and advance well-designed, clinical trials with achievable goals.
We are also expanding our resources into the exciting emerging science of healthspan, living longer without disease.
We continue to join forces with teams around the world, sharing knowledge, advancing cures, contributing to science to help end human suffering.
silence pancreatic cancer with Scruffy
Scruffy
our loyal pandemic pooches and the good, the bad and the crazy haircuts we gave them
After our Scruffy “ambassadors” raised money for life-saving lung treatments for the most severe COVID-19 cases, they have embraced a new mission, enlisting in The Cure Alliance’s new fundraising priority to silence the deadliest form of pancreatic cancer with a single-digit survival rate. SCRUFFY is the best-selling unique photo/art book documenting a dog’s life during the 2020 Pandemic, a metaphor for our courage, resiliency and hope.
Now, 100% of the proceeds from this book will go directly to FDA-authorized phase II clinical trial using 3 non-toxic low-cost generic oral drugs that, when combined, silence stage 4 adenocarcinoma pancreatic cancer. The Cure is Now. The trial will be expanded to test the drug combination on glioblastoma, colorectal, prostate and triple-negative breast cancers, all which share the same cancer mechanism.
Just click below.
The Cure Alliance Gets IRB Approval for “C3” Clinical Trial To Treat Deadliest Pancreatic Cancer AT SUNY Downstate
C3," a Combination of 3 Generic Drugs Designed to Halt Advanced Adenocarcinoma Pancreatic Cancer Moves from the Lab to Human Trials MIAMI, FLORIDA, UNITED STATES, July 4, 2023/EINPresswire.com/ -- The Cure Alliance, 501(c)(3) non-profit, announced today State...
Pancreatic Cancer has a New Formidable Foe — A Letter from the President of The Cure Alliance
Since 2015, I have served as President of The Cure Alliance, a boutique 501(C)(3) non-profit with a mission to help research scientists accelerate the pace of their discoveries from the lab to the patient’s bedside. In the very beginning, Dr. F. Charles Brunicardi...
Full Sponsorship Acquired for UC-MSC Phase III Trial to Repair Severe COVID Lung Damage
Full sponsorship of the phase II trial of UC-MS infusions to treat severe lung damage in COVID-19 ARDS has been successfully transferred to a corporate entity which will soon begin a large randomized double-blind multi-site trial. The initial research for the...